Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies

被引：4

作者：

Lichtenstein, G. R. ^{[1
]}

Moore, G. T. ^{[2
,3
]}

Soonasra, A. ^{[4
]}

Nduaka, C. I. ^{[4
]}

Kwok, K. ^{[5
]}

Wang, L. ^{[6
]}

Lawendy, N. ^{[4
]}

Chan, G. ^{[4
]}

Su, C. ^{[4
]}

Loftus, E. V., Jr. ^{[7
]}

机构：

[1] Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[2] Monash Hlth, Dept Gastroenterol, Melbourne, Vic, Australia

[3] Monash Univ, Monash Hlth, Sch Clin Sci, Melbourne, Vic, Australia

[4] Pfizer Inc, Collegeville, PA USA

[5] Pfizer Inc, New York, NY USA

[6] Pfizer Inc, Groton, CT USA

[7] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA

来源：

JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷

关键词：

D O I：

10.1093/ecco-jcc/jjy222.603

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P479

引用

页码：S351 / S352

页数：2

共 5 条

[1] Treatment with Infliximab plus Methotrexate Improves Anemia in Patients with Rheumatoid Arthritis Independent of Improvement in Other Clinical Outcome Measures-A Pooled Analysis from Three Large, Multicenter, Double-Blind, Randomized Clinical Trials [J].

Doyle, Mittie K. ;

Rahman, Mahboob U. ;

Han, Chenglong ;

Han, John ;

Giles, Jon ;

Bingham, Clifton O., III ;

Bathon, Joan .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 39 (02) :123-131

[2] The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease [J].

Koutroubakis, Ioannis E. ;

Ramos-Rivers, Claudia ;

Regueiro, Miguel ;

Koutroumpakis, Efstratios ;

Click, Benjamin ;

Schwartz, Marc ;

Swoger, Jason ;

Baidoo, Leonard ;

Hashash, Jana G. ;

Barrie, Arthur ;

Dunn, Michael A. ;

Binion, David G. .

INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) :1587-1593

[3] Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial [J].

Rubin, David T. ;

Mulani, Parvez ;

Chao, Jingdong ;

Pollack, Paul F. ;

Bensimon, Arielle G. ;

Yu, Andrew P. ;

Ghosh, Subrata .

INFLAMMATORY BOWEL DISEASES, 2012, 18 (05) :818-825

[4] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis [J].

Sandborn, William J. ;

Su, Chinyu ;

Sands, Bruce E. ;

D'Haens, Geert R. ;

Vermeire, Severine ;

Schreiber, Stefan ;

Danese, Silvio ;

Feagan, Brian G. ;

Reinisch, Walter ;

Niezychowski, Wojciech ;

Friedman, Gary ;

Lawendy, Nervin ;

Yu, Dahong ;

Woodworth, Deborah ;

Mukherjee, Arnab ;

Zhang, Haiying ;

Healey, Paul ;

Panes, Julian .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18) :1723-1736

[5] Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies [J].

Schulze-Koops, Hendrik ;

Strand, Vibeke ;

Nduaka, Chudy ;

DeMasi, Ryan ;

Wallenstein, Gene ;

Kwok, Kenneth ;

Wang, Lisy .

RHEUMATOLOGY, 2017, 56 (01) :46-57

← 1 →